iShares Biotechnology ETF (IBB) Holdings → How a $0.25 cent option contract makes my top traders feel (From DTI) (Ad) Free IBB Stock Alerts $126.49 +0.82 (+0.65%) (As of 04/26/2024 ET) Add Compare Share Share HoldingsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestSocial MediaStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestSocial Media Top 50 IBB HoldingsRankCompanyCurrent PriceWeightShares Held1AMGNAmgen$269.98+0.2%8.54%2,245,5302VRTXVertex Pharmaceuticals$397.48-0.1%8.32%1,461,4573REGNRegeneron Pharmaceuticals$883.20-0.8%8.23%636,4764GILDGilead Sciences$65.42+0.2%8.17%8,528,3455IQVIQVIA$234.88+0.4%4.42%1,343,9596MRNAModerna$107.97+1.7%3.71%2,510,169 Get the Latest News and Ratings for IBB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for iShares Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. 7BIIBBiogen$208.90+3.2%2.98%1,079,2738MTDMettler-Toledo International$1,238.09+0.4%2.73%158,2729ILMNIllumina$122.28+1.0%2.00%1,184,08110ALNYAlnylam Pharmaceuticals$143.31-0.3%1.97%938,03311ARGXargenx$372.80+1.1%1.95%375,45312BNTXBioNTech$87.21+0.6%1.93%1,548,20613WATWaters$311.30+1.0%1.88%441,99114BMRNBioMarin Pharmaceutical$80.91-1.5%1.81%1,384,78515GMABGenmab A/S$28.15+2.5%1.73%4,209,67116NBIXNeurocrine Biosciences$135.99-1.3%1.39%725,20117INCYIncyte$51.68+1.0%1.27%1,660,52318CRLCharles River Laboratories International$229.03+0.5%1.24%376,02919BGNEBeiGene$153.58+3.4%1.15%602,52320SRPTSarepta Therapeutics$128.77+1.1%1.11%660,89221UTHRUnited Therapeutics$233.85-0.9%1.11%324,44522TECHBio-Techne$64.06+2.2%1.05%1,164,50023NTRANatera$91.66+0.4%1.05%827,77924MEDPMedpace$395.93+1.6%1.00%184,44725RGENRepligen$166.58+0.6%0.88%389,05126LEGNLegend Biotech$45.30+2.0%0.78%1,146,87927BRKRBruker$80.97+0.5%0.77%673,80328ASNDAscendis Pharma A/S$135.90-0.8%0.74%362,46429ITCIIntra-Cellular Therapies$73.26+1.6%0.74%705,39030CYTKCytokinetics$65.34+0.8%0.72%743,01631EXELExelixis$23.70+0.7%0.72%2,208,32732PCVXVaxcyte$60.72+1.1%0.67%765,64033IONSIonis Pharmaceuticals$41.59-0.6%0.59%1,001,21834BPMCBlueprint Medicines$93.00+2.5%0.58%449,60935ROIVRoivant Sciences$11.03+1.4%0.54%3,602,59836RVMDRevolution Medicines$35.96+1.8%0.53%1,019,29037APLSApellis Pharmaceuticals$49.86+4.0%0.51%736,69238HALOHalozyme Therapeutics$38.57+0.3%0.51%939,10239CRSPCRISPR Therapeutics$53.91+0.3%0.49%596,82640ALKSAlkermes$24.68+1.0%0.42%1,231,479They say it’s ‘unstoppable’ – How I made 43,509% (Ad)Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.Click here now for the full story.41KRYSKrystal Biotech$156.88+0.8%0.42%176,39342INSMInsmed$24.80-0.5%0.39%1,082,03843MDGLMadrigal Pharmaceuticals$193.33-0.5%0.39%121,03444RAREUltragenyx Pharmaceutical$44.24+0.9%0.36%577,40445BBIOBridgeBio Pharma$24.88+2.3%0.35%969,88946FTREFortrea$36.350.34%655,06847CRNXCrinetics Pharmaceuticals$42.12-0.4%0.33%534,68248FOLDAmicus Therapeutics$10.28+1.1%0.32%2,144,50549XENEXenon Pharmaceuticals$40.50+1.0%0.32%540,24750BHVNBiohaven$38.97+1.1%0.31%514,013 Geographic ExposureUnited States96.8%Bermuda0.6%Canada0.6%Ireland0.5%Switzerland0.5%Virgin Islands, British0.3%Netherlands0.3%Jersey0.1%Italy0.1%Cayman Islands0.1%Currency ExposureUSD100.0%Sector ExposureHealth Care86.9%Consumer Discretionary0.5%Energy0.1%Industry ExposureBiotechnology69.5%Health Care Equipment & Supplies9.4%Health Care Providers & Services6.9%Diversified Consumer Services1.0%Distributors0.5%Renewable Energy0.1%SubIndustry ExposureBiotechnology66.3%Life Sciences Tools & Services10.3%Health Care Services6.9%Pharmaceuticals0.6%Health Care Equipment0.2%Renewable Energy Equipment0.1%Coupon Exposure0-299.9%4-60.1% Related Companies and Tools Related Companies: PPH Holdings BBH Holdings PSCH Holdings PTH Holdings BIB Holdings BTEC Holdings IBBQ Holdings FTXH Holdings MEDX Holdings JDOC Holdings This page (NASDAQ:IBB) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlaceExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
